Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Pancreatic Neoplasms 21Triple Negative Breast Neoplasms 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasm Metastasis 6Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Biliary Tract Neoplasms 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Resectable Pancreatic Cancer 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Neoplasms, Basal Cell 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Adenocarcinoma of the Pancreas 1

Interventions

Gemcitabine 8Cisplatin 8pembrolizumab 4durvalumab 4Specimen Handling 3Platinum 3Oxaliplatin 3Leucovorin 31,2-diaminocyclohexaneplatinum II citrate 3Taxes 2Nivolumab 2Magnetic Resonance Spectroscopy 2Folfox protocol 2Fluorouracil 2Biopsy 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zanidatamab 1trastuzumab deruxtecan 1tivozanib 1peposertib 1guadecitabine 1fludarabine 1dehydroftorafur 1binimetinib 1avelumab 1atezolizumab 1Trastuzumab 1Radiation Dose Hypofractionation 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gallbladder Neoplasms × Albumin-Bound Paclitaxel × 90 days × Clear all
NCT05285358 2026-06-05

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

City of Hope Medical Center

Phase 1 Suspended
12 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02495896 2026-04-29

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
61 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡